NASDAQ · Biotechnology

Agenus Inc (AGEN)

$5.97 -2.77%
44 In band Daily RSI (14) · 18 Nov 2026

Moving averages

SMA 200$5.05+18.22%

Company profile

Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company is headquartered in Lexington, Massachusetts.

SectorHealthcare
IndustryBiotechnology
Market cap$326.68M
P/E ratio30.08
EPS$0.24
Beta1.523
Dividend yield0.00%
52-week high$10.31
52-week low$2.71

Similar stocks in Biotechnology

30 days of PRO Unlimited free, no card

RSI alerts for AGEN

An email when AGEN closes below RSI 30 or above 70. Nothing else.

Data last updated 13 November 2026 at 4:17 AM EST